Delivery Order SPE2DB20D7059-SPE2DB25FGRQ6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on August 18, 2025, with a ceiling value of $8,385.46. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order contains no set-aside designation, allowing full and open competition...
- The Defense Logistics Agency awarded a delivery order valued at $1,872.90 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Oseltamivir Phosphate 45 mg capsules in unit dose packaging of 10 units. This contract represents a firm fixed price delivery order with a ceiling value of $4,604.97 and an ultimate completion date of August 20, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,109.24 firm fixed-price contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,307,107 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $5,284.09 firm-fixed-price contract has a completion date of November 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $2,129.64 and is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a $2,635.20 delivery order contract to Amerisourcebergen Drug Corporation for 75mg oseltamivir phosphate capsules. The firm fixed price contract calls for the delivery of 10 boxes of the antiviral medication to a facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this award supports DLA's stockpile of essential medicines needed to maintain military readiness and response...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRQ6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 units, with a contract value of $1,042.71. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. Oseltamivir, an antiviral medication used for influenza treatment and prophylaxis, represents the type of critical pharmaceutical commodity that falls within the scope of the DLA's medical supply chain supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/11/25 |